In Blow To Teva, Federal Circuit Refuses To Rehear Zoloft Patent Case

Law360, New York (April 4, 2005, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has refused Israeli drug maker Teva Pharmaceuticals’ request for an en-banc rehearing of its patent case over a generic version of Pfizer Inc.'s antidepressant Zoloft.

In January, the Washington-based appeals court rejected Teva's bid to overturn a lower court ruling over whether the company could seek a court ruling that it did not infringe on Pfizer's brand-name patent before it released its generic version of Zoloft.

Teva had filed an Abbreviated New Drug Application (ANDA) with the...
To view the full article, register now.